- Home
- BMRN
BMRN
BioMarin Pharmaceutical Inc.
as 02-21-2025 4:00pm EST
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | NOVATO |
| Market Cap: | N/A | IPO Year: | 1999 |
| Target Price: | $93.80 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 21 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.21 | EPS Growth: | 154.02 |
| 52 Week Low/High: | $60.63 - $94.85 | Next Earning Date: | 02-19-2025 |
| Revenue: | $2,853,915,000 | Revenue Growth: | 17.97% |
| Revenue Growth (this year): | 18.88% | Revenue Growth (next year): | 10.12% |
Latest BioMarin Pharmaceutical Inc. News
BMRN Breaking Stock News: Dive into BMRN Ticker-Specific Updates for Smart Investing
TipRanks
2 days ago
BioMarin price target raised to $80 from $78 at Scotiabank
Simply Wall St.
2 days ago
BioMarin Pharmaceutical Full Year 2024 Earnings: Beats Expectations
BioPharma Dive
2 days ago
Pfizer stops selling hemophilia gene therapy, citing weak demand
Motley Fool
2 days ago
Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today
Morningstar Research
2 days ago
Analyst Report: BioMarin Pharmaceutical Inc.
StockStory
2 days ago
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today
MT Newswires
3 days ago
UBS Adjusts Price Target on BioMarin Pharmaceutical to $113 From $109, Maintains Buy Rating
Benzinga
3 days ago
Why Is BioMarin Stock Trading Higher On Thursday?
Compare BMRN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BMRN BioMarin Pharmaceutical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.